Alexion Receives Orphan Drug Status For Dermatomyositis Treatment

The FDA has granted Orphan Drug status to Alexion Pharmaceuticals, Inc.’s humanized monoclonal antibody C5 Complement Inhibitor 5G1.1 for the treatment of patients with dermatomyositis.

Alexion is currently enrolling patients in a Phase Ib pilot clinical trial that is designed to gather clinical data regarding the safety profile and biological and clinical effects of 5G1.1 in this patient population.

The Orphan Drug designation provides Alexion with market exclusivity for seven years from the drug’s approval date.

“Dermatomyositis is a rare and severe inflammatory disorder, the rash and debilitating weakness of which we believe may be alleviated by 5G1.1,” said Leonard Bell, M.D., President and CEO of Alexion.

“We are enthused to work in collaboration with the FDA to as rapidly as possible attempt to provide an innovative therapy for this small, but underserved patient population.

We are continuing to aggressively pursue 5G1.1 in this and other potential orphan indications with the objective of providing relief to multiple underserved and previously unrecognised patient groups.”

Alexion is engaged in the discovery and development of therapeutic products aimed at treating patients with a wide array of severe disease states, including cardiovascular and autoimmune disorders, inflammation and cancer.

Alexion’s two lead product candidates are currently in eight clinical development programs.

5G1.1-SC, in collaboration with Procter & Gamble, is in a Phase IIb cardiopulmonary bypass efficacy trial and in two Phase II myocardial infarction efficacy trials.

Shop Dragon Pharma LLC Online

Masteron 200 - Discount Price

Administration: Injection
Active Ingredient: Drostanolone Enanthate
Producer: Dragon Pharma
Pack: 30 x 10 mL vial (200 mg/mL)
Price: 30 x $49.00

Nolvadex

Selective Estrogen Receptor Modulator
Primary Chemical Name: Tamoxifen Citrate
Branded by: Dragon Pharma LLC
Package: 1 X 100 pastilles (20 mg/tab)

Masteron 100 - Bulk Price

Administration: Injection
Main Ingredient: Drostanolone Di-Propionate
Produced by: Dragon Pharma Labs
Amount: 10 x 10 mL vial (100 mg/mL)
Price: 10 x $49.00

TriTren 150 - Discount Price

Administration: Injection
Basic Substance: Tri Trenbolone
Branded by: Dragon Pharmaceuticals
Package: 30 x 10 mL vial (150 mg/mL)
Price: 30 x $55.00

Primobolan 100 - Cheap Price

Administration: Injection
Base Component: Methenolone Enanthate
Produced by: Dragon Pharma
Amount: 20 x 10 mL vial (100 mg/mL)
Price: 20 x $65.00

Enantat 250 - Bulk Price

Administration: Injection
Basic Constituent: Testosterone Enanthate
Made by: Dragon Pharmaceutical
Package: 10 x 10 mL vial (250 mg/mL)
Price: 10 x $36.00

Trenbolone 100 - Discount Price

Administration: Injection
Base Chemical Name: Trenbolone Acetate
Produced by: Dragon Pharmaceutical
Unit: 30 x 10 mL vial (100 mg/mL)
Price: 30 x $45.00

Parabolan 100 [10 Vials]

Injectable Steroid for Muscle Growth
Basic Component: Trenbolone Hexahydrobenzylcarbonate
Made by: Dragon Pharma LLC
10 Vials [10 mL per Vial (100 mg/ml)]
Price: 10 x $69.00 = $690.00 in Total

Deca 300

Injectable Steroid for Muscle Growth
Main Ingredient: Nandrolone Decanoate
Branded by: Dragon Pharma Labs
10 mL Sterile Multi-dose Vial (300 mg/mL)

EQ 300 [10 Vials]

Injectable Steroid for Muscle Growth
Primary Ingredient: Boldenone Undecylenate
Producer: Dragon Pharmaceuticals
10 Vials [10 mL per Vial (300 mg/ml)]
Price: 10 x $42.00 = $420.00 in Total

TriTren 150

Base Chemical Name: Tri Trenbolone
Produced by: Dragon Pharma LLC
Package: 10 x 10 mL vial (150 mg/mL)

Suspension 100

Basic Substance: Testosterone Suspension
Producer: Dragon Pharma Labs
Package: 10 mL vial (100 mg/mL)